Business Insights
Record Job Satisfaction at Medis
This year for the first time we also measured the NetPromoterScore (NPS) index which was as high as 79%!
Read More
Medis Group ends its 2020 financial year with almost 12% revenue growth
Medis will continue its strategic investments to obtain high, double-digit, year-on-year growth and to reach the set financial goals for 2025.
Read More
We talked to Izolda Areskiene, Baltic States Regional Manager, Medis Pharma
Under her leaderhip Medis Pharma Lithuania has grown into a reliable, effective and profitable company with high ethical and compliance standards.
Read More
Interview with Aleksandar Spasovski, Country Manager of Medis in Bulgaria
Medis Pharma Bulgaria strives to improve the quality of life of patients by offering high-quality products.
Read More
Infected With Enthusiasm – Evolution of the Serbian Pharma Market
Medis is one of the fastest-growing pharmaceutical companies in Serbia. We talked to the Country Manager, Elina Markovic.
Read More
Country in Focus: Serbia
The total value of the pharmaceutical market in Serbia is € 833 million and it is estimated that it will grow by 6.7% from 2019 to 2021.
Read More
First-Hand Experience with Imunoglukan – Story of Nadja
For Nadja Ott, a pharmacist and Brand Manager, this period at Medis is very stressful, but at the same time, it is also exciting.
Read More
We Maintain the Best Balance Between Development and Risk
Interview with Erna Slana, Managing Director of the Finance and Accounting Division at Medis.
Read More
Medis Proudly Announces a New Partnership with Biocodex Nordics
Exclusive distribution agreement for Medis’ latest development Ladiva, which will be commercialized by Biocodex Nordics in Finland, represents a new important...
Read More
Medis Received the Platinum Creditworthiness Certificate of Excellence for 2020
The Bisnode Analytics Services has ranked Medis among the 1.5% of the most successful, reliable, credible and low-risk companies for cooperation with other...
Read More
A new partnership with Neurim Pharmaceuticals Ltd.
Our exclusive distribution agreement for the commercialization of Slenyto® represents an important milestone for both companies.
Read More
In 2019 Medis generated 70% revenues from international markets
The rapid expansion and the introduction of important novel therapeutic options further enhanced the position of Medis as the leading independent company for...
Read More
Martina Perharič, the CEO of Medis, Recipient of the 2019 Artemis Award
The Managers’ Association of Slovenia presented the award for outstanding achievements in the field of management to Martina Perharič, the CEO of Medis.
Read More
Medis is now present also in the Baltic countries and Slovakia
From 2020, Medis offers its partners a single entry point for 15 countries in the CEE region.
Read More
Catch the healthy rhythm in 2020!
The rhythm of the heart, the rhythm of youth, the rhythm of the senses, the rhythm of words, the rhythm of music and the rhythm of dance ... in the new year,...
Read More
Happy Birthday, Medis!
Thirties are an important period in an individual's life, a period that combines a great deal of knowledge and experience, a lot of bold feats, just as many...
Read More
Survey: Medis employees are satisfied and engaged
In general, the satisfaction was highest with the relationships with colleagues within the teams and the kind of work we do.
Read More
Medis is Expanding to Follow the Continuous Growth
Medis’ partners benefit from the full scope of services needed for the successful commercialization of a medicine/medicinal products in the CSEE region.
Read More
Country in Focus: Croatia
Croatia is a CSEE country at the crossroads of the Central and Southeast Europe, next to the Adriatic Sea.
Read More
New Look for the 30th Anniversary
For the 30th anniversary, we have launched our new website and we are excited to present its new look.
Read More